Goldman Sachs’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.89M | Sell |
|
|||||
|
2025
Q4 | $8.49M | Sell |
|
|||||
|
2025
Q3 | $10.3M | Buy |
|
|||||
|
2025
Q2 | $6.46M | Sell |
|
|||||
|
2025
Q1 | $11M | Sell |
|
|||||
|
2024
Q4 | $16.2M | Buy |
|
|||||
|
2024
Q3 | $10.8M | Buy |
|
|||||
|
2024
Q2 | $3.54M | Sell |
|
|||||
|
2024
Q1 | $2.82M | Buy |
|
|||||
|
2023
Q4 | $507K | Buy |
|
|||||
|
2023
Q3 | $359K | Sell |
|
|||||
|
2023
Q2 | $881K | Sell |
|
|||||
|
2023
Q1 | $772K | Buy |
|
|||||
|
2022
Q4 | $236K | Sell |
|
|||||
|
2022
Q3 | $72K | Buy |
|
|||||
|
2022
Q2 | $34K | Sell |
|
|||||
|
2022
Q1 | $90K | Sell |
|
|||||
|
2021
Q4 | $126K | Buy |
|
|||||
|
2021
Q3 | $208K | Buy |
|
|||||
|
2021
Q2 | $304K | Sell |
|
|||||
|
2021
Q1 | $508K | Buy |
|
|||||
|
2020
Q4 | $164K | Buy |
|